Gliclazide + Metformin Tablets(Er) Suppliers & Bulk Manufacturers

Available Forms: Tablets(ER)

Available Strengths: Gliclazide 30 mg/60 mg + Metformin 500/1000 mg

Reference Brands: Glizid-M XR(US & EU)

Category: Diabetes

Gliclazide + Metformin Tablets(ER) is available in Tablets(ER) and strengths such as Gliclazide 30 mg/60 mg + Metformin 500/1000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Gliclazide + Metformin Tablets(ER) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Gliclazide + Metformin Tablets(ER) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Gliclazide + Metformin Extended-Release (ER) tablets are not FDA-approved in the United States but are widely authorized and marketed in the European Union under national procedures. The combination is indicated for managing type 2 diabetes mellitus in adults inadequately controlled on monotherapy. Products are registered under well-known brands like Diamicron MR + Metformin XR. European regulatory agencies mandate bioequivalence, stability, and pharmacodynamic evidence to ensure safety and efficacy. Although not listed in the U.S. Orange Book, this fixed-dose combination supports enhanced patient compliance and glycemic control. For sourcing support and B2B pharmaceutical trade, visit Pharmatradz.com.